207 related articles for article (PubMed ID: 20490597)
1. Mizoribine protects against bleomycin-induced lung injury.
Matsui K; Ueda H; Terada M; Azuma N; Okamura H; Sano H
Mod Rheumatol; 2010 Oct; 20(5):471-7. PubMed ID: 20490597
[TBL] [Abstract][Full Text] [Related]
2. Protection against bleomycin-induced lung injury by IL-18 in mice.
Nakatani-Okuda A; Ueda H; Kashiwamura S; Sekiyama A; Kubota A; Fujita Y; Adachi S; Tsuji Y; Tanizawa T; Okamura H
Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L280-7. PubMed ID: 15792964
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
[TBL] [Abstract][Full Text] [Related]
4. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
[TBL] [Abstract][Full Text] [Related]
5. Use of tetrandrine to differentiate between mechanisms involved in silica-versus bleomycin-induced fibrosis.
Ma JY; Barger MW; Hubbs AF; Castranova V; Weber SL; Ma JK
J Toxicol Environ Health A; 1999 Jun; 57(4):247-66. PubMed ID: 10406349
[TBL] [Abstract][Full Text] [Related]
6. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
7. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
[TBL] [Abstract][Full Text] [Related]
8. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
9. Changes in expression of cytokines in polyhexamethylene guanidine-induced lung fibrosis in mice: Comparison of bleomycin-induced lung fibrosis.
Kim MS; Kim SH; Jeon D; Kim HY; Lee K
Toxicology; 2018 Jan; 393():185-192. PubMed ID: 29175452
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
[TBL] [Abstract][Full Text] [Related]
11. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
Cai Y; Kimura S
PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
[TBL] [Abstract][Full Text] [Related]
12. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice.
Hagiwara SI; Ishii Y; Kitamura S
Am J Respir Crit Care Med; 2000 Jul; 162(1):225-31. PubMed ID: 10903246
[TBL] [Abstract][Full Text] [Related]
13. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
14. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
15. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
16. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
17. FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice.
Yara S; Kawakami K; Kudeken N; Tohyama M; Teruya K; Chinen T; Awaya A; Saito A
Clin Exp Immunol; 2001 Apr; 124(1):77-85. PubMed ID: 11359445
[TBL] [Abstract][Full Text] [Related]
18. Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice.
Shimaoka Y; Tajima S; Fujimori F; Yamabayashi C; Moriyama H; Terada M; Takada T; Suzuki E; Bando M; Sugiyama Y; Narita I
Lung; 2009; 187(5):331-9. PubMed ID: 19672658
[TBL] [Abstract][Full Text] [Related]
19. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
